Riskpilot← Back to searchSign inGet full accessUS ENOVACOR ApS
APSActiveCVR 34877440Erling Jacobsens Gade 67Research and experimental development on natural sciences and engineering · NACE 7210Est. 2012— employees
Revenue 2024
DKK 114K
+100% vs 2023
EBITDA margin
100.0%
+100% vs 2023
Equity ratio
-664.9%
Financial strength
Net profit 2024
DKK 66K
+628% vs 2023
| Revenue | DKK 114K | +100% |
| EBITDA | DKK 114K | +100% |
| Net profit | DKK 66K | +628% |
| Total assets | DKK 127K | +26% |
| Equity | DKK -842K | +7% |
| Employees | — | — |
Legal name
US ENOVACOR ApS
CVR number
34877440
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
29. november 2012
Share capital
DKK 120.000
Employees
—
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af én direktør eller den samlede direktion.
Company purpose
Selskabets formål er udvikling, kommercialisering og salg af opfindelser indenfor medicobranchen samt dermed beslægtet virksomhed.
Address
Erling Jacobsens Gade 67
Phone
+4551542997
Email
tfb@dadlnet.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -48 | -86 | 1.606 | -82 | -24 | -24 | -24 | 10 | -8 | 9 | 57 | 114 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -742 | -246 | 984 | -381 | -173 | -98 | -121 | -509 | -81 | -50 | 57 | 114 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -742 | -246 | 984 | -381 | -173 | -98 | -121 | -509 | -81 | -50 | 57 | 114 |
| Net financials | -28 | -37 | -108 | -11 | -87 | -29 | -43 | -18 | -104 | 663 | -48 | -48 |
| Profit before tax | -770 | -283 | 877 | -392 | -259 | -127 | -164 | -527 | -184 | 613 | 9 | 66 |
| Tax | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Net profit | -770 | -283 | 877 | -392 | -259 | -127 | -164 | -527 | -184 | 613 | 9 | 66 |
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 165 | 160 | 1.778 | 483 | 215 | 515 | 381 | 146 | 71 | 59 | 101 | 127 |
| Equity | -670 | -953 | 124 | -268 | -527 | -655 | -819 | -1.346 | -1.530 | -917 | -908 | -842 |
| Long-term debt | 545 | 1.071 | 1.276 | 0 | 0 | 822 | 852 | 1.205 | 1.306 | 957 | 994 | 956 |
| Short-term debt | 289 | 42 | 377 | 751 | 742 | 348 | 348 | 287 | 295 | 20 | 15 | 12 |
| Total debt | 834 | 1.113 | 1.654 | 751 | 742 | 1.170 | 1.200 | 1.492 | 1.601 | 977 | 1.009 | 968 |
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
20132024
Equity ratio
-664.9%
This company
38.2%
Market median
-1841% vs market
20132024
Return on equity
6642100.0%
This company
18.4%
Market median
+36098270% vs market
20132024
Net profit margin
58.1%
This company
8.1%
Market median
+617% vs market
20132024
Asset turnover
0.90×
This company
1.12×
Market median
+20% vs market
20132024
Debt / equity
1.15×
This company
0.62×
Market median
-85% vs market
20132024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2012-11-29 – 2013-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JM Management | Management | 2013 | — | — |
JØ Management | Management | 2012 | — | — |
TF Management | Management | 2024 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
USABCD HOLDING ApS | Company | 50.0% | 50.0% | 2015 |
ENOVACOR II ApS | Company | 50.0% | 50.0% | 2015 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
ERIK SLOTH HOLDING ApS
US ENOVACOR ApS Board members of US ENOVACOR ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| John Michael Hasenkam | Management | 0 companies |
| Jeppe Øvli Øvlesen | Management | 0 companies |
| Thomas Fichtner Bendtsen | Management | 0 companies |